Products for Research Use Only
RegisterLogin

Glofitamab (Anti-CD20 & CD3)

CAT: 0957-A4015Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0957-A4015Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Glofitamab is a T-cell–engaging bispecific antibody that targets CD3 and CD20, demonstrating significant antitumor activity and durable responses in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) . It works by binding to CD20 on B cells and CD3 on T cells, promoting T-cell-mediated lysis of malignant B cells. MW: 170.28 KD.
CAS Number
946415-62-9
Synonyms
RG6026, RO7082859
Target
CD markers
Activity
Transmembrane Transporters
Storage Conditions
-80°C (avoid freeze-thaw cycles)

Related Products

CatalogName
A4045Odronextamab (Anti-CD20 & CD3)
A4008Epcoritamab (Anti-CD20 & CD3)
A4045-1mgOdronextamab (Anti-CD20 & CD3)
A4008-1mgEpcoritamab (Anti-CD20 & CD3)
A3174-01Mosunetuzumab (Anti-CD20 & CD3e)
A3174-1mg*25Mosunetuzumab (Anti-CD20 & CD3e)
A3174-1mgMosunetuzumab (Anti-CD20 & CD3e)
A3174-1mg*5Mosunetuzumab (Anti-CD20 & CD3e)
A2971-1mgOfatumumab (Anti-CD20)
A2969-1mg*5Ocaratuzumab (Anti-CD20)

Alternative Products

CatalogName
C00881Glofitamab (Anti-CD20 & CD3)
BIO0972SM-1mgAnti-human CD20 & CD3 (Glofitamab Biosimilar)
GTR18699405-01Anti-CD20 & CD3 Reference Antibody (Glofitamab Biosimilar)
YR1582-01Anti-Human CD3E & CD20 Recombinant Antibody (Glofitamab)
C00874-1mgEpcoritamab (Anti-CD20 & CD3)
C00909Odronextamab (Anti-CD20 & CD3)
F2100-50Anti-CD20/CD3 Antibody (Mosunetuzumab)
F1388-1Anti-CD3 & CD20 Antibody (Epcoritamab)
100836-2Anti-CD20-Anti-CD3 Bispecific Antibody
GTR18703859-01CD3 & CD20 Antibody

Popular Products